Although TZD have been used commercially in the treatment of type 2 diabetes to improve insulin resistance and lower plasma glucose levels, issues related to unwanted side effects of these agents are problematic [11,22]; therefore, there is an urgent need to look into alternative natural PPARγ ligands. This evidence concerns the gene PPARG and Insulin resistance.